Quantitative studies of splenic erythropoiesis in polycythaemia vera and myelofibrosis.
A quantitative scanning method employing cyclotron-produced 52Fe has been developed to assess splenic erythropoiesis in patients with myeloproliferative disorders. In 12 patients with myelofibrosis splenic uptake of 52Fe was from 5.0% to 48% of the injected dose. Although a single patient with classical polycythaemia vera had a minor uptake of 2.8% of six other patients with this diagnosis showed no concentration of isotope in the splenic area. The fraction of 52Fe in the spleen of four patients with 'transitional' myeloproliferative disorders characterized by a high red cell mass, hypercellular bone marrow and a leucoerythroblastic blood film varied from 5% to 41%. No clear relationship was noted between the degree of splenic erythropoiesis as defined by this technique and the level of haemoglobin, the degree of splenomegaly, the effectiveness of erythropoiesis of traditional 59Fe surface counting. If splenectomy is considered in patients with myelofibrosis splenic 52Fe quantitation will provide more precise data on the contribution of splenic erythropoiesis than 59Fe surface counting alone.
D004920:Erythropoiesis; D006801:Humans; D007504:Iron Radioisotopes; D011087:Polycythemia Vera / Q000097:blood* / Q000175:diagnosis; D055728:Primary Myelofibrosis / Q000097:blood* / Q000175:diagnosis; D011877:Radionuclide Imaging; D013154:Spleen / Q000166:cytology* / Q000378:metabolism
D007504:Iron Radioisotopes